nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.00123	0.00123	CbGpPWpGaD
Vemurafenib—BRAF—Disease—ABCA4—cleft lip	0.00123	0.00123	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—FGF3—cleft lip	0.00122	0.00122	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ARHGAP29—cleft lip	0.00122	0.00122	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—FGFR3—cleft lip	0.0012	0.0012	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—FGFR3—cleft lip	0.0012	0.0012	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—FGF9—cleft lip	0.00119	0.00119	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—FGFR1—cleft lip	0.00119	0.00119	CbGpPWpGaD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—NOS3—cleft lip	0.00119	0.00119	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—FGFR1—cleft lip	0.00119	0.00119	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—FGFR2—cleft lip	0.00119	0.00119	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—FGFR2—cleft lip	0.00119	0.00119	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—FGFR2—cleft lip	0.00119	0.00119	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—FGFR1—cleft lip	0.00118	0.00118	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—FGFR3—cleft lip	0.00118	0.00118	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—FGFR2—cleft lip	0.00118	0.00118	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—FGFR1—cleft lip	0.00118	0.00118	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—FGFR2—cleft lip	0.00117	0.00117	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—FGF2—cleft lip	0.00117	0.00117	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—FGFR2—cleft lip	0.00117	0.00117	CbGpPWpGaD
Vemurafenib—RAF1—TSH signaling pathway—MYC—cleft lip	0.00116	0.00116	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—FGFR2—cleft lip	0.00116	0.00116	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—FGFR1—cleft lip	0.00115	0.00115	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Insulin receptor—FGF2—cleft lip	0.00113	0.00113	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—WNT9B—cleft lip	0.00113	0.00113	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—FGFR3—cleft lip	0.00113	0.00113	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—NOS3—cleft lip	0.00112	0.00112	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—FGFR3—cleft lip	0.00112	0.00112	CbGpPWpGaD
Vemurafenib—BRAF—Disease—SLC19A1—cleft lip	0.00112	0.00112	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—FGFR3—cleft lip	0.00112	0.00112	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—FGFR3—cleft lip	0.00111	0.00111	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—FGFR1—cleft lip	0.00111	0.00111	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—FGFR1—cleft lip	0.00111	0.00111	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—FGFR1—cleft lip	0.00111	0.00111	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—FGFR1—cleft lip	0.0011	0.0011	CbGpPWpGaD
Vemurafenib—BRAF—Disease—WNT3—cleft lip	0.00109	0.00109	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—FGFR1—cleft lip	0.00109	0.00109	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—FGFR1—cleft lip	0.00109	0.00109	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—FGFR1—cleft lip	0.00108	0.00108	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—MTHFR—cleft lip	0.00107	0.00107	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—FGFR2—cleft lip	0.00105	0.00105	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—FGFR3—cleft lip	0.00104	0.00104	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—FGFR3—cleft lip	0.00104	0.00104	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—FGFR3—cleft lip	0.00104	0.00104	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.00104	0.00104	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—FGFR3—cleft lip	0.00104	0.00104	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.00103	0.00103	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—FGFR3—cleft lip	0.00103	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—FGFR3—cleft lip	0.00103	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—FGFR3—cleft lip	0.00102	0.00102	CbGpPWpGaD
Vemurafenib—BRAF—PDGFR-beta signaling pathway—MYC—cleft lip	0.00101	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—FGF10—cleft lip	0.00101	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	0.000979	0.000979	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—MTR—cleft lip	0.000969	0.000969	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—FGF2—cleft lip	0.000968	0.000968	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—WNT9B—cleft lip	0.000963	0.000963	CbGpPWpGaD
Vemurafenib—RAF1—Disease—WNT9B—cleft lip	0.000952	0.000952	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—WNT9B—cleft lip	0.000943	0.000943	CbGpPWpGaD
Vemurafenib—RAF1—Retinoblastoma (RB) in Cancer—MYC—cleft lip	0.000932	0.000932	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FGF7—cleft lip	0.000929	0.000929	CbGpPWpGaD
Vemurafenib—BRAF—Disease—TCN2—cleft lip	0.000929	0.000929	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—FGF2—cleft lip	0.000927	0.000927	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—FGF2—cleft lip	0.000927	0.000927	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.000925	0.000925	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NOG—cleft lip	0.000923	0.000923	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—FGF2—cleft lip	0.000912	0.000912	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—WNT3—cleft lip	0.000896	0.000896	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—FGF7—cleft lip	0.000893	0.000893	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TGFB3—cleft lip	0.000886	0.000886	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—FGF2—cleft lip	0.000871	0.000871	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—FGF2—cleft lip	0.000867	0.000867	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—MYC—cleft lip	0.000866	0.000866	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IRF6—cleft lip	0.000864	0.000864	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—FGF2—cleft lip	0.000862	0.000862	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ABCA4—cleft lip	0.000858	0.000858	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—FGF2—cleft lip	0.000858	0.000858	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FGF8—cleft lip	0.000858	0.000858	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—NOS3—cleft lip	0.000855	0.000855	CbGpPWpGaD
Vemurafenib—RAF1—B Cell Receptor Signaling Pathway—MYC—cleft lip	0.000854	0.000854	CbGpPWpGaD
Vemurafenib—RAF1—Disease—ABCA4—cleft lip	0.000848	0.000848	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—ABCA4—cleft lip	0.000841	0.000841	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—FGF8—cleft lip	0.000824	0.000824	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—MTR—cleft lip	0.000821	0.000821	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—ABCA4—cleft lip	0.000816	0.000816	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—FGFR2—cleft lip	0.000808	0.000808	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—FGF2—cleft lip	0.000807	0.000807	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.000807	0.000807	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—FGF2—cleft lip	0.000807	0.000807	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—FGF2—cleft lip	0.0008	0.0008	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—MYC—cleft lip	0.000795	0.000795	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—FGF2—cleft lip	0.000795	0.000795	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—FGF2—cleft lip	0.000793	0.000793	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—FGF2—cleft lip	0.00079	0.00079	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SLC19A1—cleft lip	0.000776	0.000776	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SLC19A1—cleft lip	0.000769	0.000769	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—WNT3—cleft lip	0.000765	0.000765	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.00076	0.00076	CbGpPWpGaD
Vemurafenib—RAF1—Disease—WNT3—cleft lip	0.000756	0.000756	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—FGFR1—cleft lip	0.000753	0.000753	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—WNT3—cleft lip	0.000749	0.000749	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FGF7—cleft lip	0.000722	0.000722	CbGpPWpGaD
Vemurafenib—BRAF—Disease—SPRY2—cleft lip	0.000722	0.000722	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.000715	0.000715	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—FGFR3—cleft lip	0.000712	0.000712	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FGF3—cleft lip	0.000698	0.000698	CbGpPWpGaD
Vemurafenib—RAF1—PDGFR-beta signaling pathway—MYC—cleft lip	0.000697	0.000697	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—FGFR1—cleft lip	0.000682	0.000682	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FGF9—cleft lip	0.000681	0.000681	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—FGF3—cleft lip	0.000671	0.000671	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—MYC—cleft lip	0.000667	0.000667	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FGF8—cleft lip	0.000667	0.000667	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—WNT9B—cleft lip	0.000666	0.000666	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—FGF9—cleft lip	0.000654	0.000654	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—FGF10—cleft lip	0.00065	0.00065	CbGpPWpGaD
Vemurafenib—BRAF—Disease—MTR—cleft lip	0.000644	0.000644	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—SLC19A1—cleft lip	0.000644	0.000644	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TCN2—cleft lip	0.000643	0.000643	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NOG—cleft lip	0.000639	0.000639	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TCN2—cleft lip	0.000637	0.000637	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—MTR—cleft lip	0.000634	0.000634	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ABCA4—cleft lip	0.000594	0.000594	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—SUMO1—cleft lip	0.000592	0.000592	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.000584	0.000584	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FGF10—cleft lip	0.000574	0.000574	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—SLC19A1—cleft lip	0.000567	0.000567	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—FGF10—cleft lip	0.000551	0.000551	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—MYC—cleft lip	0.00055	0.00055	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—FGF2—cleft lip	0.00055	0.00055	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FGF3—cleft lip	0.000543	0.000543	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FGF7—cleft lip	0.000541	0.000541	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—TCN2—cleft lip	0.000534	0.000534	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—WNT3—cleft lip	0.000529	0.000529	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FGF9—cleft lip	0.000529	0.000529	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SPRY2—cleft lip	0.000506	0.000506	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGF7—cleft lip	0.000506	0.000506	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SPRY2—cleft lip	0.0005	0.0005	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGF7—cleft lip	0.0005	0.0005	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FGF8—cleft lip	0.0005	0.0005	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000497	0.000497	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGF7—cleft lip	0.000495	0.000495	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SPRY2—cleft lip	0.000495	0.000495	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—PTCH1—cleft lip	0.000491	0.000491	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—FGFR1—cleft lip	0.000486	0.000486	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—TCN2—cleft lip	0.000469	0.000469	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGF8—cleft lip	0.000467	0.000467	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGF8—cleft lip	0.000461	0.000461	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FGFR2—cleft lip	0.000461	0.000461	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGF8—cleft lip	0.000457	0.000457	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FGF10—cleft lip	0.000446	0.000446	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MTR—cleft lip	0.000445	0.000445	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—FGFR2—cleft lip	0.000443	0.000443	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MTR—cleft lip	0.000442	0.000442	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FGFR1—cleft lip	0.00043	0.00043	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PTCH1—cleft lip	0.000419	0.000419	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—FGFR1—cleft lip	0.000412	0.000412	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FGF3—cleft lip	0.000407	0.000407	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FGFR3—cleft lip	0.000406	0.000406	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FGF9—cleft lip	0.000397	0.000397	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—FGFR3—cleft lip	0.00039	0.00039	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGF3—cleft lip	0.00038	0.00038	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGF3—cleft lip	0.000375	0.000375	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGF3—cleft lip	0.000372	0.000372	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGF9—cleft lip	0.000371	0.000371	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—MTR—cleft lip	0.00037	0.00037	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGF9—cleft lip	0.000366	0.000366	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGF9—cleft lip	0.000363	0.000363	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FGFR2—cleft lip	0.000358	0.000358	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—FGF2—cleft lip	0.000355	0.000355	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SPRY2—cleft lip	0.00035	0.00035	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGF7—cleft lip	0.00035	0.00035	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—SLC19A1—cleft lip	0.00035	0.00035	CbGpPWpGaD
Vemurafenib—BRAF—Disease—MTHFR—cleft lip	0.000345	0.000345	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—NOS3—cleft lip	0.000344	0.000344	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FGF10—cleft lip	0.000334	0.000334	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FGFR1—cleft lip	0.000334	0.000334	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—MTR—cleft lip	0.000325	0.000325	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGF8—cleft lip	0.000323	0.000323	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FGFR3—cleft lip	0.000316	0.000316	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FGF2—cleft lip	0.000314	0.000314	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGF10—cleft lip	0.000313	0.000313	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGF10—cleft lip	0.000309	0.000309	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGF10—cleft lip	0.000306	0.000306	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—FGF2—cleft lip	0.000301	0.000301	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PTCH1—cleft lip	0.00029	0.00029	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—TCN2—cleft lip	0.00029	0.00029	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SLC19A1—cleft lip	0.000289	0.000289	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FGFR2—cleft lip	0.000268	0.000268	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGF3—cleft lip	0.000263	0.000263	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGF9—cleft lip	0.000256	0.000256	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGFR2—cleft lip	0.000251	0.000251	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FGFR1—cleft lip	0.00025	0.00025	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGFR2—cleft lip	0.000248	0.000248	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGFR2—cleft lip	0.000246	0.000246	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SLC19A1—cleft lip	0.000245	0.000245	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FGF2—cleft lip	0.000244	0.000244	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NOS3—cleft lip	0.00024	0.00024	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—TCN2—cleft lip	0.000239	0.000239	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MTHFR—cleft lip	0.000239	0.000239	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MTHFR—cleft lip	0.000236	0.000236	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FGFR3—cleft lip	0.000236	0.000236	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGFR1—cleft lip	0.000234	0.000234	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGFR1—cleft lip	0.000231	0.000231	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGFR1—cleft lip	0.000229	0.000229	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—TYMS—cleft lip	0.000227	0.000227	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGFR3—cleft lip	0.000221	0.000221	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGFR3—cleft lip	0.000218	0.000218	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGFR3—cleft lip	0.000216	0.000216	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGF10—cleft lip	0.000216	0.000216	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—TCN2—cleft lip	0.000203	0.000203	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—MTR—cleft lip	0.000201	0.000201	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—TYMS—cleft lip	0.000199	0.000199	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—MTHFR—cleft lip	0.000198	0.000198	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SLC19A1—cleft lip	0.000189	0.000189	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NOS3—cleft lip	0.000185	0.000185	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FGF2—cleft lip	0.000183	0.000183	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—MTHFR—cleft lip	0.000174	0.000174	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGFR2—cleft lip	0.000174	0.000174	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGF2—cleft lip	0.000171	0.000171	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGF2—cleft lip	0.000169	0.000169	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NOS3—cleft lip	0.000168	0.000168	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGF2—cleft lip	0.000167	0.000167	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOS3—cleft lip	0.000166	0.000166	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—MTR—cleft lip	0.000166	0.000166	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOS3—cleft lip	0.000165	0.000165	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGFR1—cleft lip	0.000162	0.000162	CbGpPWpGaD
Vemurafenib—BRAF—Disease—MYC—cleft lip	0.000159	0.000159	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—TCN2—cleft lip	0.000156	0.000156	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGFR3—cleft lip	0.000153	0.000153	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—MTR—cleft lip	0.00014	0.00014	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—NOS3—cleft lip	0.000138	0.000138	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—TYMS—cleft lip	0.000123	0.000123	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—NOS3—cleft lip	0.000122	0.000122	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGF2—cleft lip	0.000118	0.000118	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NOS3—cleft lip	0.000117	0.000117	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MYC—cleft lip	0.000112	0.000112	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MYC—cleft lip	0.00011	0.00011	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MYC—cleft lip	0.000109	0.000109	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—MTR—cleft lip	0.000108	0.000108	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—MTHFR—cleft lip	0.000108	0.000108	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—TYMS—cleft lip	0.000102	0.000102	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—MTHFR—cleft lip	8.88e-05	8.88e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—TYMS—cleft lip	8.61e-05	8.61e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MYC—cleft lip	7.72e-05	7.72e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—MTHFR—cleft lip	7.52e-05	7.52e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NOS3—cleft lip	7.5e-05	7.5e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—TYMS—cleft lip	6.64e-05	6.64e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NOS3—cleft lip	6.19e-05	6.19e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—MTHFR—cleft lip	5.8e-05	5.8e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NOS3—cleft lip	5.25e-05	5.25e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NOS3—cleft lip	4.05e-05	4.05e-05	CbGpPWpGaD
